Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/REJOICE-Ovarian01-Phase-2-3-Trial-of-Raludotatug-Deruxtecan-Initiated-in-Patients-with-Platinum-Resi-46348637/?utm_source=whatsapp&utm_medium=social&utm_campaign=share